Madrigal Pharmaceuticals Inc (NAS:MDGL)
$ 467.32 -25.79 (-5.23%) Market Cap: 10.80 Bil Enterprise Value: 10.31 Bil PE Ratio: 0 PB Ratio: 20.57 GF Score: 31/100

Madrigal Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 07:30 PM GMT
Release Date Price: $425.85 (-2.24%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MDGL.OQ - Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 07:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome everyone to the Madrigal Fireside chat at the forty-sixth annual TD Cowan Healthcare Conference. I'm covering analyst Ritu Bal, and with us here from Madrigal in order is Bill Sebold, CEO, David Sorgel, CMO, and Marty dear, CFO. Welcome, everyone.

Thank you for being here. So maybe let's start with revenue growth, and company goals. We came off another great earnings report. The launch is going exceptionally well, and at the same time you did 3 BD deals in about 6 months, like within, I don't know, 14 months of Dave joining, to build the pipeline. And before we get into the questions, maybe Bill, can you just give a brief, like 3 minute update on. The strategy and and performance so far
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot